SCHEMBL9628660

SCHEMBL9628660

Cc1sc(-c2ccccc2F)nc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.48
HTR2B P41595 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24919879 0.84 HTR2B (0.64) HTR2B
SCHEMBL2090208 0.81 APEX1 (0.50) APEX1HTR2B
SCHEMBL28077207 0.81 ALDH1A1 (0.46) APEX1
SCHEMBL2090207 0.79 APEX1 (0.48) APEX1HTR2B
SCHEMBL12209850 0.77 NPC1 (0.45) APEX1HTR2B
SCHEMBL9630548 0.76 ALOX5 (0.62)
SCHEMBL9629598 0.75
SCHEMBL9629483 0.73 ALOX5 (0.58)
SCHEMBL9629266 0.73 ALOX5 (0.63)
SCHEMBL13801079 0.72 ALDH1A1 (0.52) APEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5124342-A Antiinflammatory, antiarthritic agents; antiallergens; skin disorders ABBOTT LABORATORIES (US) 1992-06-23 US disclosed
EP-0457803-A4 4-HYDROXYTHIAZOLES AS 5-LIPOXYGENASE INHIBITORS 1991-12-04 EP disclosed
EP-0457803-A1 4-HYDROXYTHIAZOLES AS 5-LIPOXYGENASE INHIBITORS ABBOTT LABORATORIES (US) 1991-11-27 EP disclosed
WO-1990009801-A1 4-HYDROXYTHIAZOLES AS 5-LIPOXYGENASE INHIBITORS ABBOTT LABORATORIES (US) 1990-09-07 WO disclosed
WO-1990009381-A1 4-HYDROXYTHIAZOLES AS 5-LIPOXYGENASE INHIBITORS ABBOTT LABORATORIES (US) 1990-08-23 WO disclosed